Third Arc Bio Stock
HealthTechLooking to sell Third Arc Bio stock or options?
Third Arc Bio is a biotech company focused on the research and development of multifunctional antibodies. Their platform aims to deliver groundbreaking therapies for solid tumors, inflammation, and immunological disorders by producing antibodies that form immune synapses for precise activation or inhibition of T cells. This enables medical companies to access advanced antibodies for treating immune system-related diseases.
Foresite Capital, T. Rowe Price Group, Freepoint Capital Group, Goldman Sachs Asset Management, Omega Funds, Vida Ventures (Boston), AbbVie Ventures, BVF Partners, Abrdn, Logos Capital, Janus Henderson Investors, Marshall Wace, Cormorant Asset Management, Hillhouse Investment Group.